posted
OPGX, News company per phone conversation today from another board. May be time to load up!
Spoke with Dan (CEO) here is the lowdown. First let me say that its really hard to ***** to a company if you are a trader vs. an investor. So with that being said the O/S is 2.2 billion Dan did say that there are PR'S heading our way. He said he wanted to release weeks ago but that he wanted to wait for the right moment. I mentioned the shares being dumped at the end of the day and his opinion was convertibles are being sold. Mind you we have seen allot of buying and in my opinion this will go up again soon.
IP: Logged |
posted
If you can get in at 0.0005, this is a great entry point. You may get in at 0.0004 but It could run up to 0.0007 quickly by 11:00 AM Monday. I own 7 million shares. Holding for a expected update? if this happens, we should see 0.001 - 0.0012 by the end of the day. But without news, this will stay in the 0.0004 to 0.0007 range.
IP: Logged |
posted
i know exactly what you mean hot-pepper and considering my other picks lately and the small amount i have in this one, i'm in no need to liquidate this one...patience is key for this... good entry point here
IP: Logged |
posted
OPGX, Confirmed 20 Billion A/S! Must read if you own? I sold my 7 million this morning. Subject: Very Important Question Regarding Company recent filing? From: "Ascione Gail (DOS)" <Gail.Ascione@state.de.us> Date: Mon, 5 Oct 2009 09:27:28 -0400 To: <xxxxxx@epix.net>
File# 3835548 this company did file an amendment reflecting a stock increase from common 2,500,000,000 par value 0.00001 Preferred stock 20,000,000 par value 0.00001 to common 20,000,000,000 par value 0.00001 preferred stock 20,000,000 par value 0.00001 this amendment was filed in our office on 9/22/2009
-----Original Message----- From: xxxxxx@epix.net Sent: Sunday, October 04, 2009 4:29 PM To: Dosdoc Web (DOS) Subject: Very Important Question Regarding Company recent filing? Importance: High
Optigenex, Inc, Trading Symbol OPGX Can you confirm if this has been increased to 20,020,000,000 {amendment filed 9/22/2009. This has been reported 09/29/2009 by a Stockholder of the stock listed above. This was confirmed by an online chat by an agent. There has been no company update on this action. As a large shareholder I am trying to get confirmation if this is true?
IP: Logged |
posted
NEEEEEEEEEWWWSSS FINALLY WHERE MY LONGS AT!
Optigenex Inc. Announces Supply And License Agreement With Suracell Inc. To Utilize The AC-11(R) Trademark And Technology For Or
Company plans to market dietary supplements under the brand name Suracell with AC-11(R) (Financial terms were not disclosed).
NEW YORK, Oct. 21 /PRNewswire-FirstCall/ -- Optigenex Inc. (Pinksheets: OPGX) announced today the signing of a Supply and Trademark License Agreement with Suracell Inc. to provide its patented ingredient AC-11(R) for use in a focused nutritional and age management dietary supplement program. The agreement coupled with Suracell's marketing plans will provide another platform to introduce Optigenex's technology under the registered trademark AC-11(R) to health conscious consumers in the United States, Canada and South Korea.
Beginning in January 2010, Suracell will be marketing a specific dietary supplement regimen. Participants will complete lifestyle questionnaires and will be asked to provide specimens for testing of key bio markers that will form the basis for a focused nutritional supplement program utilizing the diverse line of Suracell formulated products with AC-11(R).
All-natural, herbal-extracted and patented AC-11(R) is marketed by over 100 manufacturers and marketing companies in Japan, Europe, the Middle East, the United States and Canada in a variety of anti-aging cosmetic, dietary supplement and advanced DNA care products.
Daniel Zwiren, president and CEO of Optigenex Inc. said, "We are excited to add Suracell to our family of customers. We believe Suracell's scientifically validated formulas are an ideal fit for the unique properties of AC-11(R), including natural DNA repair, immune enhancement and inhibition of pro-inflammatory agents. The licensing relationship we are entering into today will allow both companies to expand significantly their respective businesses and market penetration.
A Suracell spokesperson added, "The addition of AC -11(R) to the proprietary customized Suracell formulations gives us a product line unparalleled in its potential benefits to its customers. The evolving science surrounding AC 11(R) promises a very exciting future for our product offerings.
About Suracell Inc.:
Suracell Inc. provides personal genetic health programs formulated to measure, assess treat and monitor the body's individual genetic needs. The testing and analysis programs are designed to pinpoint deficiencies and damage in an individual's DNA and provide personalized recommended protocols consisting of specially formulated nutraceuticals and positive lifestyle choices.
About Optigenex Inc.:
Optigenex Inc. (http://www.optigenex.com/) is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring AC-11(R) (formerly known as C-MED-100(R)), a patented compound, as its core technology. AC- 11(R) is the bioactive, water-soluble form of the medicinal herb Uncaria tomentosa. For more information about Optigenex please email the company at: .
* The statements made in this press release have not been evaluated by the Food and Drug Administration. The products mentioned in this release are not intended to diagnose, treat, cure or prevent any disease.
CONTACT: For more information about Optigenex please email the company at:
DATASOURCE: Optigenex Inc.
CONTACT: For more information about Optigenex please email the company
IP: Logged |
posted
Finally OPGX is kicking. Let's watch it all week. It's at 60% now, but watch up and down movements. The volume is at who knows what....1,160,273,677 at 10:03 AM CST.
IP: Logged |
posted
The jump to .0009 a couple of days ago was something else, but it has droped to 0.0005 on the asking side this morning. I sold at 0.0008 a couple of days ago and bought back more shares yesterday at 0.0005.
IP: Logged |
posted
I plan to hold on to the shares. She is in the flying mood. This week could bring a lot of loaves in my opinion. Let's watch this baby this week! I may just buy more, hopefully it does not go south.
IP: Logged |
posted
I hope so!! She does not seem to have a PR company. Do you have a target price? or any info on when the products will reach the public? Glad to know I'm not alone on this one.
IP: Logged |
posted
Lockman you were right. How low could this one go and check out the huge volume. I gues the bottom has been reached. I would only do us well by moving upwards from this level up. I picked up some more shares today so that I may balance my overall average cost per share.
IP: Logged |
posted
News: Optigenex Inc. Agrees to Long-Term License Granting Promethean Corporation Exclusive North American Distribution Rights for Cosmeceutical and Dietary Supplement Products Containing AC-11(R) in the Direct Sales (Network Marketing) Distribution Channel 9:22a ET January 4, 2010 (Market Wire) Optigenex Inc. (PINKSHEETS: OPGX) announced today the signing of a long term exclusive license agreement with Promethean Corporation for distribution and marketing of branded cosmeceutical and dietary supplement products containing AC-11(R), a patented, all-natural rain forest botanical extract manufactured by Optigenex that helps the body's natural ability to repair damaged DNA as a result of overexposure to the sun and other environmental stressors. Under the new agreement, Promethean through its wholly owned subsidiary, Ceres Living will market the "AIO Premium Cellular Health(TM)" line of advanced dietary supplements, as well as specially formulated next generation topical skin care products with AC-11(R). The contract vests Promethean with exclusivity in the North American "Direct Sales" or "Network Marketing" distribution channel coinciding with the expiration of similar channel rights previously held by former licensee. In addition to North American Direct Sales channel rights, Promethean will exercise exclusive rights and sublicensing rights in all channels in China and certain additional non-exclusive channel rights in North and Central America and Australia.
Daniel Zwiren, president and CEO of Optigenex Inc. said, "Teaming up with Promethean promises to be the perfect start of a new decade for Optigenex. The management at Promethean and its wholly owned subsidiary, Ceres Living are professionals with a proven record in business management and the Direct Sales (Network Marketing) distribution channel. We are excited to see the AC-11(R) brand and our unique theme of DNA health associated with the innovative technologies behind AIO Premium Cellular Health(TM)."
Matthew Henninger, Chairman & CEO of Promethean Corporation, added, "We had wanted to work with the Optigenex team and their product AC-11(R) since before we developed the AIO Premium Cellular Health(TM) product line. Now that timing has allowed our two companies to align, we look forward to continued collaborative research and development of products that offer the best technologies in cellular health and nutrition."
About Optigenex Inc.:
Optigenex Inc. is a technology-based developer of proprietary anti-aging ingredients for various health-related industries, including wellness, beauty and dietary supplements. AC-11(R) (formerly known as C-MED-100(R)) is the company's patented all-natural extract from the medicinal herb Uncaria tomentosa. From its origins in the Amazon Rain Forest, AC-11(R) delivers a unique bioactive compound of water soluble carboxy alkyl esters (CAEs(TM)) that form the backbone of the company's revolutionary approach to DNA care and healthy aging. For more information about Optigenex please visit our website: www.optigenex.com
About Promethean Corporation:
Promethean Corp. ("Promethean") is a New York City based Health Care related products and services company that develops, manufactures and distributes its own products. The company through its wholly owned subsidiary, Ceres Living produces and sells the AIO Premium Cellular Health(TM) product line. The company develops Advanced Nutraceuticals, Advanced Personal Care products and other Nutritional and Wellness Products and Services that it plans to sell in multiple channels of distribution. For more information about Promethean Corporation, please contact the company at (212)-355-5129.
*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to treat, diagnose, cure or prevent any disease.
Contact: Optigenex Inc. Dan Zwiren president and CEO Optigenex Inc. dzwiren@optigenex.com 201 355 2098
posted
Optigenex Inc. Announces Expansion of AC-11(R) Sales in Japan ThroughIts Exclusive Partner Itochu Corporation
Feb 3, 2010 08:09:35 (ET)
NEW YORK, NY, Feb 03, 2010 (MARKETWIRE via COMTEX) -- Optigenex Inc. (PINKSHEETS: OPGX) announced today the introduction of AC-11(R)-melon, a new oral capsule formulated by its partner, Itochu Corporation, utilizing patented AC-11(R) in combination with GliSODin, a cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD). The protective benefits of GliSODin, in conjunction with the therapeutic benefits of AC-11(R) to help repair naturally the body's damaged DNA, offer a unique and highly effective combination for cellular wellness to health-conscious consumers*. Japan traditionally has been known for its highly educated and well-informed consumer population, especially in the area of healthy aging. The enthusiastic response to Koyo-sa Japan's rollout of AC-11(R)-melon validates this reputation and constitutes another step forward in the evolution of AC-11(R) as one of the most popular health and wellness technologies in Japan.
Itochu acts in partnership with Optigenex under a Long-Term Exclusive Supply and Trademark Licensing Agreement to market AC-11(R) bulk material and consumer products containing AC-11(R) under sublicenses in Japan and several other Asian countries. To date, the company has introduced AC-11(R) successfully to over 110 companies in the cosmetic and dietary supplement market, with 130 plus products containing AC-11(R) currently being marketed and sold in Japan. AC-11(R) is the patented, all-natural rain forest botanical extract produced by Optigenex that helps the body's natural ability to repair damage to DNA due to multiple causes, including harmful effects of UV radiation (over-exposure to the sun), stress, environmental pollution and other stressors. In its standard bulk powder form, AC-11(R) supplement may be consumed orally or combined with liposomes and other delivery mechanisms for topical application to the skin.
Daniel Zwiren, president and CEO of Optigenex Inc., said, "We are excited about the Koyo-sa's new product and anticipate further expanded growth in sales this year of AC-11(R) to Japan, not only for AC-11(R)-melon but for other AC-11(R) nutraceutical products as our message for cellular wellness and healthy aging continues to take hold with our customers."
Yusuke Itou of Itochu Corporation added, "Koyo-sa is the largest network marketing company in Japan. We are extremely pleased that they have decided to market AC-11(R)-melon and that they recognize the importance of combining synergistic ingredients for new and robust products." Mr. Itou continued, "We fully expect to augment sales and volume of bulk purchases significantly in 2010 and beyond as our customers integrate AC-11(R) into existing products and formulate new products utilizing AC-11(R) as the main ingredient."
About ITOCHU Corporation:
Itochu Corporation is one of Japan's leading trading companies and is engaged in a wide variety of businesses, including food products, personal care products, textiles, technology multimedia, metals, energy, chemicals, forest products, retail and financial services. Itochu has approximately 45,690 employees, maintains over 130 offices and owns over 651 subsidiaries and affiliates around the world. Itochu's sales last year reached 11.58 trillion yen (U.S. $95 billion).
About Optigenex Inc.:
Optigenex Inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring as its core product AC-11(R) (formerly known as C-MED-100(R)) a patented, bioactive and water soluble rain forest compound derived from the medicinal herb Uncaria tomentosa. For more information about Optigenex please visit our website: www.optigenex.com
*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to diagnose, treat, cure or prevent any disease.
Contact: Optigenex Inc. Dan Zwiren president and CEO Optigenex Inc. dzwiren@optigenex.com 201 355 2098
posted
Optigenex Inc. (PINKSHEETS: OPGX) announced today the introduction of AC-11(R)-melon, a new oral capsule formulated by its partner, Itochu Corporation, utilizing patented AC-11(R) in combination with GliSODin, a cantaloupe melon extract rich in the vegetable antioxidant enzyme (SOD). The protective benefits of GliSODin, in conjunction with the therapeutic benefits of AC-11(R) to help repair naturally the body's damaged DNA, offer a unique and highly effective combination for cellular wellness to health-conscious consumers*. Japan traditionally has been known for its highly educated and well-informed consumer population, especially in the area of healthy aging. The enthusiastic response to Koyo-sa Japan's rollout of AC-11(R)-melon validates this reputation and constitutes another step forward in the evolution of AC-11(R) as one of the most popular health and wellness technologies in Japan.
Itochu acts in partnership with Optigenex under a Long-Term Exclusive Supply and Trademark Licensing Agreement to market AC-11(R) bulk material and consumer products containing AC-11(R) under sublicenses in Japan and several other Asian countries. To date, the company has introduced AC-11(R) successfully to over 110 companies in the cosmetic and dietary supplement market, with 130 plus products containing AC-11(R) currently being marketed and sold in Japan. AC-11(R) is the patented, all-natural rain forest botanical extract produced by Optigenex that helps the body's natural ability to repair damage to DNA due to multiple causes, including harmful effects of UV radiation (over-exposure to the sun), stress, environmental pollution and other stressors. In its standard bulk powder form, AC-11(R) supplement may be consumed orally or combined with liposomes and other delivery mechanisms for topical application to the skin.
Daniel Zwiren, president and CEO of Optigenex Inc., said, "We are excited about the Koyo-sa's new product and anticipate further expanded growth in sales this year of AC-11(R) to Japan, not only for AC-11(R)-melon but for other AC-11(R) nutraceutical products as our message for cellular wellness and healthy aging continues to take hold with our customers."
Yusuke Itou of Itochu Corporation added, "Koyo-sa is the largest network marketing company in Japan. We are extremely pleased that they have decided to market AC-11(R)-melon and that they recognize the importance of combining synergistic ingredients for new and robust products." Mr. Itou continued, "We fully expect to augment sales and volume of bulk purchases significantly in 2010 and beyond as our customers integrate AC-11(R) into existing products and formulate new products utilizing AC-11(R) as the main ingredient."
About ITOCHU Corporation:
Itochu Corporation is one of Japan's leading trading companies and is engaged in a wide variety of businesses, including food products, personal care products, textiles, technology multimedia, metals, energy, chemicals, forest products, retail and financial services. Itochu has approximately 45,690 employees, maintains over 130 offices and owns over 651 subsidiaries and affiliates around the world. Itochu's sales last year reached 11.58 trillion yen (U.S. $95 billion).
About Optigenex Inc.:
Optigenex Inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring as its core product AC-11(R) (formerly known as C-MED-100(R)) a patented, bioactive and water soluble rain forest compound derived from the medicinal herb Uncaria tomentosa. For more information about Optigenex please visit our website: www.optigenex.com
*The statements made in this press release have not been evaluated by the Food and Drug Administration (FDA). The products mentioned herein are not intended to diagnose, treat, cure or prevent any disease.
Contact: Optigenex Inc. Dan Zwiren president and CEO Optigenex Inc. dzwiren@optigenex.com 201 355 2098
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
